📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Synthesis of the highly selective p38 MAPK inhibitor UR-13756 for possible therapeutic use in Werner syndrome. (2010)

First Author: Bagley MC

Attributed to: Dissecting the cause of premature replicative senescence of Werner syndrome cells using selective chemical inhibitors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.4155/fmc.09.163

PubMed Identifier: 21426186

Publication URI: http://europepmc.org/abstract/MED/21426186

Type: Journal Article/Review

Volume: 2

Parent Publication: Future medicinal chemistry

Issue: 2

ISSN: 1756-8919